Clinical Trial Update: Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant human bile salt-stimulated lipase (rhBSSL) added to infant formula or pasteurized breast milk in preterm infants; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• rhBSSL (recombinant human bile salt-stimulated lipase)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Prevention of Growth Restriction | Phase 3 | Status: TERMINATED